U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Nikki's Ginger Tea LLC - 446205 - 03/14/2018
  1. Warning Letters

CLOSEOUT LETTER

Nikki's Ginger Tea LLC MARCS-CMS 446205 —

Recipient:
Nikki's Ginger Tea LLC

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

 
 
Chicago District Office
550 W. Jackson Blvd., Suite 1500
Chicago, IL 60661
Telephone: (312) 353-5863
Fax: (312) 596-4187 

March 14, 2018
 

VIA UPS

Andrena N. Sasser, Co-Owner
Monique D. Sasser, Co-Owner
Nikki’s Ginger Tea, LLC
231 E. Grand Boulevard
Detroit, MI 48207

Dear Mses. Sasser,

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 2015-DET-07, dated March 18, 2015. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Byron J. Ho, DVM
Compliance Officer
Human and Animal Food Operations
Division East 6

Back to Top